David Sidransky

David Sidransky is a Professor of Oncology, Otolaryngology, Urology, Pathology, and Genetics at Johns Hopkins University, where David has worked since July 1988. Sidransky is also a medical oncologist and researcher. In addition to academic responsibilities, Sidransky serves as the Chairman of the Board for Ayala Pharmaceuticals, Champions Oncology, Inc., and Advaxis, Inc., and holds board member positions at Galmed Pharmaceuticals Ltd. and Orgenesis Inc. Previous leadership roles include Chairman of the Board for Tamir Biotechnology and member of the Board of Directors for Rosetta Genomics and Celsus Therapeutics PLC. Sidransky's educational background includes a Doctor of Medicine from Baylor College of Medicine and a Bachelor of Science in Chemistry from Brandeis University.